Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

3.1K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
3.1K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

1.0K
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.0K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.3K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

633
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
633
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

9.5K
Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
9.5K
Development of Immunocompetence01:22

Development of Immunocompetence

1.2K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Teclistamab in Elderly Patients With Relapsed/Refractory Multiple Myeloma: A Subgroup Analysis of the French RetrosTECtive Cohort.

EJHaem·2026
Same author

Real-Life Management of Patients Aged 80 Years Old and Over With Multiple Myeloma: Results of the EMMY Cohort.

Clinical lymphoma, myeloma & leukemia·2024
Same author

Non-occlusive Small Bowel Ischemia Related to Postoperative Feeding Jejunostomy Tube Use After Esophagectomy for Cancer: Propensity Score Analysis of the AFC-FREGAT Database.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·2022
Same author

Stress induced by messenger ribonucleic acid (RNA) vaccination may reveal acute adrenal insufficiency.

Endocrine·2021
Same author

Is There an Optimal Definition for a Positive Circumferential Resection Margin in Locally Advanced Esophageal Cancer?

Annals of surgical oncology·2021
Same author

Patient-reported outcomes after oesophagectomy in the multicentre LASER study.

The British journal of surgery·2021
Same journal

Robotic radical anterogradepancreatosplenectomy (r-RAMPS)(with video).

Journal of visceral surgery·2026
Same journal

Pancreatodudenectomy versus total pancreatectomy in patients at high risk of pancreatic fistula: A systematic review of the literature.

Journal of visceral surgery·2026
Same journal

Re: "Aorto-duodenal fistula: what should we do?"

Journal of visceral surgery·2026
Same journal

Transgastric singleport laparoscopic resection of a gastroesophageal junction stromal tumor (with video).

Journal of visceral surgery·2026
Same journal

Revascularization of the hepatic artery by reimplantation of the gastroduodenal artery during a pancreatoduodenectomy (with video).

Journal of visceral surgery·2026
Same journal

Surgery is no longer the only effective treatment for obesity: What does this means?

Journal of visceral surgery·2026
See all related articles

Related Experiment Video

Updated: Apr 4, 2026

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
11:12

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Published on: September 13, 2024

1.0K

Immunonutrition.

C Mariette1

  • 1Department of Gastrointestinal and General Surgery, Lille Regional University Hospital.

Journal of Visceral Surgery
|August 29, 2015
PubMed
Summary
This summary is machine-generated.

Preoperative immunonutrition is recommended for all digestive cancer surgery patients, regardless of nutritional status. Postoperative immunonutrition is crucial for malnourished patients to aid recovery.

Keywords:
CancerGuidelinesImmunonutritionMorbidityReviewSurgery

More Related Videos

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice
08:43

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice

Published on: January 31, 2020

7.4K

Related Experiment Videos

Last Updated: Apr 4, 2026

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
11:12

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Published on: September 13, 2024

1.0K
Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice
08:43

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice

Published on: January 31, 2020

7.4K

Area of Science:

  • Oncology
  • Surgical Nutrition
  • Gastroenterology

Background:

  • Digestive cancer surgery poses significant nutritional challenges.
  • Optimizing patient nutritional status is critical for surgical outcomes.
  • Immunonutrition has emerged as a potential strategy to mitigate surgical stress.

Purpose of the Study:

  • To establish evidence-based recommendations for immunonutrition in digestive cancer surgery.
  • To define the optimal timing and duration of immunonutrition administration.
  • To identify patient populations who benefit most from immunonutrition.

Main Methods:

  • Systematic review and meta-analysis of randomized controlled trials.
  • Grade A level of evidence assessment.
  • Analysis of preoperative and postoperative immunonutrition protocols.

Main Results:

  • Strong evidence supports preoperative immunonutrition 5-7 days before surgery for all patients.
  • Postoperative immunonutrition for 5-7 days is beneficial for malnourished patients.
  • Continuation of immunonutrition until 60% oral intake is achieved aids recovery.

Conclusions:

  • Immunonutrition is a vital component of perioperative care for digestive cancer patients.
  • Early initiation and appropriate duration of immunonutrition improve surgical outcomes.
  • Tailoring immunonutrition to patient nutritional status is essential for maximizing benefits.